Close

Can-Fite BioPharma (CANF) Announces Summary of Existing Out-licensing Deals with Potential Milestone Payments of up to approximately $130 million

Go back to Can-Fite BioPharma (CANF) Announces Summary of Existing Out-licensing Deals with Potential Milestone Payments of up to approximately $130 million
CAN-FITE BIOPHARMA LTD. (NYSE: CANF) Delayed: 1.92 -0.02 (1.03%)
Previous Close $1.94    52 Week High $3.89 
Open $1.94    52 Week Low $1.85 
Day High $1.97    P/E N/A 
Day Low $1.91    EPS $0.00 
Volume 12,246       

(NASDAQ: CFBI) Delayed: 10.08 --0 (-0%)
Previous Close $10.08    52 Week High
Open $41.64    52 Week Low
Day High $10.08    P/E N/A 
Day Low $10.08    EPS
Volume 206